Immunologic dysfunction in scleroderma: evidence for increased mast cell releasability and hla–dr positivity in the dermis
Open Access
- 1 May 1988
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 31 (5) , 672-677
- https://doi.org/10.1002/art.1780310514
Abstract
To investigate the role of mast cells and cell-mediated immunity in the pathogenesis of scleroderma, we studied wheal size after skin testing with compound 48/80, a liberator of mast cell histamine, and demonstrated increased mast cell releasability in skin that appeared normal, adjacent to involved skin. Immunofluorescent staining for HLA–DR showed dermal positivity in 12 of 13 involved- and 9 of 13 uninvolved-skin biopsy specimens from scleroderma patients, compared with only 1 of 10 controls. By immunoperoxidase staining, most of the DR positivity was found in fibroblast-like cells. These findings further support the notion of immunologic dysfunction in scleroderma.This publication has 6 references indexed in Scilit:
- Increased Dermal Mast Cell Populations in Progressive Systemic Sclerosis: A Link in Chronic Fibrosis?Annals of Internal Medicine, 1985
- Lymphocytes in the skin of patients with progressive systemic sclerosisArthritis & Rheumatism, 1984
- Unusual structure of human splenic sinusoids revealed by monoclonal antibodiesHistochemistry and Cell Biology, 1984
- Detection of T and B cell antigens hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method.Journal of Histochemistry & Cytochemistry, 1980
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980
- Sjögren's Syndrome in Progressive Systemic SclerosisAnnals of Internal Medicine, 1977